Neovasc’s Reducer granted breakthrough device designation from FDA

Neovasc’s Reducer, a medical device for the treatment of refractory angina and not currently approved for commercial sale in the U.S., has been granted Breakthrough Device designation by the FDA.
https://thefly.com/landingPageNews.php?id=2802079